| scholarly article | Q13442814 |
| P2093 | author name string | Andy Weyer | |
| Jose Reyna | |||
| Tabitha Galindo | |||
| P2860 | cites work | Transient receptor potential ankyrin 1 receptor stimulation by hydrogen peroxide is critical to trigger pain during monosodium urate-induced inflammation in rodents | Q47850637 |
| Attenuation of experimental arthritis in TRPV1R knockout mice | Q48690273 | ||
| Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation. | Q48748066 | ||
| Exercise for osteoarthritis of the knee | Q24186685 | ||
| Non-steroidal anti-inflammatory drugs for acute gout | Q24193584 | ||
| Colchicine for acute gout | Q24194373 | ||
| TRPC channel activation by extracellular thioredoxin | Q24650851 | ||
| Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action | Q24804189 | ||
| Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis | Q24816854 | ||
| Hypoxia and its implications in rheumatoid arthritis | Q26739909 | ||
| Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis | Q26751187 | ||
| The Effect of Intra-articular Corticosteroids on Articular Cartilage: A Systematic Review | Q26775431 | ||
| Emerging regulators of the inflammatory process in osteoarthritis | Q26829840 | ||
| Management of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline | Q28109639 | ||
| The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans | Q28238213 | ||
| Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans | Q28272480 | ||
| Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. | Q43699726 | ||
| Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial | Q44299491 | ||
| Oral irritation by mustard oil: self-desensitization and cross-desensitization with capsaicin | Q44542299 | ||
| Infections in patients with rheumatoid arthritis treated with biologic agents | Q44952372 | ||
| Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis | Q45714037 | ||
| [EXPRESS] Monoclonal antibodies for chronic pain: a practical review of mechanisms and clinical applications | Q46156381 | ||
| GRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models | Q46245642 | ||
| Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice | Q46438614 | ||
| TRPV1 mediates cell death in rat synovial fibroblasts through calcium entry-dependent ROS production and mitochondrial depolarization. | Q46709161 | ||
| TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger hyperalgesia and inflammation in a model of acute gout | Q46900003 | ||
| Involvement of transient receptor potential melastatin-8 (TRPM8) in menthol-induced calcium entry, reactive oxygen species production and cell death in rheumatoid arthritis rat synovial fibroblasts | Q46944503 | ||
| Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis. | Q47273817 | ||
| Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II | Q28396036 | ||
| Urate crystal induced inflammation and joint pain are reduced in transient receptor potential ankyrin 1 deficient mice--potential role for transient receptor potential ankyrin 1 in gout | Q28543261 | ||
| The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion | Q28573570 | ||
| Radiological assessment of osteo-arthrosis | Q29614927 | ||
| Role of cytokines in rheumatoid arthritis | Q29620713 | ||
| Systematic review of topical capsaicin for the treatment of chronic pain | Q30829459 | ||
| The Influence of Weather Conditions on Joint Pain in Older People with Osteoarthritis: Results from the European Project on OSteoArthritis | Q33465948 | ||
| OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. | Q33532831 | ||
| TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan | Q33595202 | ||
| Impact of central and peripheral TRPV1 and ROS levels on proinflammatory mediators and nociceptive behavior. | Q34075112 | ||
| Contribution of transient receptor potential ankyrin 1 to chronic pain in aged mice with complete Freund's adjuvant-induced arthritis | Q34109166 | ||
| Clinical practice. Gout | Q34162182 | ||
| Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis | Q34322559 | ||
| Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis | Q34456671 | ||
| The effects of intraarticular resiniferatoxin in experimental knee-joint arthritis | Q34468227 | ||
| Human neutrophils in auto-immunity | Q34520590 | ||
| Chondroprotective role of the osmotically sensitive ion channel transient receptor potential vanilloid 4: age- and sex-dependent progression of osteoarthritis in Trpv4-deficient mice. | Q34522629 | ||
| Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries | Q34592490 | ||
| Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain | Q34818013 | ||
| Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study | Q35092969 | ||
| Advances in the medical treatment of rheumatoid arthritis | Q35102474 | ||
| Treatment of acute gout: a systematic review | Q35125970 | ||
| Oxidative stress in secondary osteoarthritis: from cartilage destruction to clinical presentation? | Q35128894 | ||
| The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis | Q35138392 | ||
| Capsaicin-sensitive sensory nerves exert complex regulatory functions in the serum-transfer mouse model of autoimmune arthritis | Q35146980 | ||
| Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis | Q35554444 | ||
| Fibroblast-like synovial cells from normal and inflamed knee joints differently affect the expression of pain-related receptors in sensory neurones: a co-culture study | Q35769063 | ||
| Afferent drive elicits ongoing pain in a model of advanced osteoarthritis | Q35855535 | ||
| Environmental cold exposure increases blood flow and affects pain sensitivity in the knee joints of CFA-induced arthritic mice in a TRPA1-dependent manner | Q35891181 | ||
| Role of capsaicin-sensitive nerves and tachykinins in mast cell tryptase-induced inflammation of murine knees | Q36037155 | ||
| Polymodal Transient Receptor Potential Vanilloid (TRPV) Ion Channels in Chondrogenic Cells | Q36088570 | ||
| Comparison of reliability and responsiveness of patient-reported clinical outcome measures in knee osteoarthritis rehabilitation | Q36213481 | ||
| Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice | Q36477409 | ||
| The molecular and cellular basis of cold sensation | Q36657613 | ||
| Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist. | Q50898491 | ||
| Synovial TRPV1 is upregulated by 17-β-estradiol and involved in allodynia of inflamed temporomandibular joints in female rats. | Q51012013 | ||
| Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. | Q52661324 | ||
| Gout | Q54087165 | ||
| Neuronal IL-17 receptor upregulates TRPV4 but not TRPV1 receptors in DRG neurons and mediates mechanical but not thermal hyperalgesia. | Q54472108 | ||
| Interleukin-21 induces migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis. | Q55034856 | ||
| Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. | Q55047291 | ||
| CD147 up-regulates calcium-induced chemotaxis, adhesion ability and invasiveness of human neutrophils via a TRPM-7-mediated mechanism. | Q55072775 | ||
| Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism | Q56169415 | ||
| Rheumatoid arthritis | Q56656479 | ||
| The association between arthritis and the weather | Q57134073 | ||
| A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor α-induced inflammatory hyperalgesia and Freund's complete adjuvant-induced monarthritis | Q57898575 | ||
| Differences in synovial tissue infiltrates between anti–cyclic citrullinated peptide–positive rheumatoid arthritis and anti–cyclic citrullinated peptide–negative rheumatoid arthritis | Q58234928 | ||
| Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis | Q61848957 | ||
| Monosodium iodoacetate-induced inflammation and joint pain are reduced in TRPA1 deficient mice – potential role of TRPA1 in osteoarthritis | Q62641626 | ||
| Capsaicin effects on substance P and CGRP in rat adjuvant arthritis | Q63208639 | ||
| Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis | Q63406968 | ||
| Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis | Q68053396 | ||
| Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints | Q69654179 | ||
| Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis | Q69696757 | ||
| Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis | Q72693365 | ||
| Intraneuronal substance P contributes to the severity of experimental arthritis | Q72749066 | ||
| The analgesic efficacy of topical capsaicin is enhanced by glyceryl trinitrate in painful osteoarthritis: a randomized, double blind, placebo controlled study | Q73313656 | ||
| Gout | Q73472123 | ||
| Rheumatoid Arthritis of the Hip | Q73743573 | ||
| Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis | Q80461012 | ||
| Expression of ion channels of the TRP family in articular chondrocytes from osteoarthritic patients: changes between native and in vitro propagated chondrocytes | Q82213748 | ||
| TRPV1-related modulation of spinal neuronal activity and behavior in a rat model of osteoarthritic pain | Q82293771 | ||
| Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extension | Q82534212 | ||
| Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase | Q82991564 | ||
| Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis | Q83147793 | ||
| Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats | Q84060628 | ||
| Rheumatoid arthritis: where are we now? | Q84425357 | ||
| Moderate extracellular acidification inhibits capsaicin-induced cell death through regulating calcium mobilization, NF-κB translocation and ROS production in synoviocytes | Q84504734 | ||
| Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008 | Q84617958 | ||
| Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production | Q86208498 | ||
| Participation of the TRPV1 receptor in the development of acute gout attacks | Q86637247 | ||
| Inhibition of transient receptor potential melastatin 7 (TRPM7) channel induces RA FLSs apoptosis through endoplasmic reticulum (ER) stress | Q87682822 | ||
| Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule | Q36679390 | ||
| New therapies for treatment of rheumatoid arthritis | Q36849874 | ||
| Vanilloid receptor TRPV1-positive sensory afferents in the mouse ankle and knee joints | Q36862026 | ||
| Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator | Q36903272 | ||
| TRPA1 and cold transduction: an unresolved issue? | Q37124273 | ||
| Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes. | Q37169416 | ||
| What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel? | Q37198480 | ||
| Intra-articular Hyaluronic Acid in Treating Knee Osteoarthritis: a PRISMA-Compliant Systematic Review of Overlapping Meta-analysis | Q37247421 | ||
| The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study | Q37321292 | ||
| Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation | Q37604540 | ||
| The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies. | Q37606213 | ||
| A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis | Q37633796 | ||
| Anti-inflammatory effects of hyaluronan in arthritis therapy: Not just for viscosity. | Q37723272 | ||
| Gout therapeutics: new drugs for an old disease | Q37780849 | ||
| The Role of Transient Receptor Potential Cation Channels in Ca2+ Signaling | Q37791280 | ||
| A "cute" desensitization of TRPV1. | Q37798852 | ||
| Genetic epidemiology of hip and knee osteoarthritis | Q37809747 | ||
| The transient receptor potential family of ion channels | Q37852820 | ||
| Gout: current insights and future perspectives | Q37940064 | ||
| Reactive oxygen species: the 2-edged sword of osteoarthritis | Q38034003 | ||
| The fibroblast as a therapeutic target in rheumatoid arthritis | Q38096642 | ||
| Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities. | Q38216302 | ||
| Zucapsaicin for the treatment of neuropathic pain. | Q38244583 | ||
| Role of IL-17 and IL-22 in autoimmunity and cancer | Q38268323 | ||
| An update on the pathophysiology of osteoarthritis | Q38829272 | ||
| Hypotonic stress promotes ATP release, reactive oxygen species production and cell proliferation via TRPV4 activation in rheumatoid arthritis rat synovial fibroblasts | Q38919808 | ||
| Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies | Q39070631 | ||
| Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis | Q39139509 | ||
| Acidosis of synovial fluid correlates with synovial fluid leukocytosis | Q39194003 | ||
| Biologics in the treatment of chronic pain: a new era of therapy? | Q39194391 | ||
| Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis | Q39364082 | ||
| Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes. | Q40295239 | ||
| Using gait analysis to assess weight bearing in rats with Freund׳s complete adjuvant-induced monoarthritis to improve predictivity: Interfering with the cyclooxygenase and nerve growth factor pathways | Q41190112 | ||
| Auranofin: repurposing an old drug for a golden new age. | Q41474201 | ||
| Hypoxia-inducible factor-1α (HIF1α) switches on transient receptor potential ankyrin repeat 1 (TRPA1) gene expression via a hypoxia response element-like motif to modulate cytokine release | Q42325393 | ||
| Stimulation of human TRPA1 channels by clinical concentrations of the antirheumatic drug auranofin | Q42713895 | ||
| Vanilloid receptor TRPV1-mediated phosphorylation of ERK in murine adjuvant arthritis | Q43140210 | ||
| Homologous and heterologous desensitization of capsaicin and mustard oil responses utilize different cellular pathways in nociceptors | Q43151051 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2018-10-15 | |
| P1433 | published in | Pharmaceuticals | Q15750667 |
| P1476 | title | Evidence for Transient Receptor Potential (TRP) Channel Contribution to Arthritis Pain and Pathogenesis | |
| P478 | volume | 11 |
| Q64229773 | A Network Pharmacology Approach to Explore Mechanism of Action of Longzuan Tongbi Formula on Rheumatoid Arthritis |
| Q90522829 | Identification and Quantification of Transient Receptor Potential Vanilloid 1 (TRPV1) in Equine Articular Tissue |
| Q113621906 | TRP channels and monoterpenes: Past and current leads on analgesic properties |
Search more.